AnalystsLeonid TimashevLeonid Timashev's Stock Forecasts
AnalystsLeonid Timashev
Analyst Ranking
Top 8%
#378 out of 5202 analysts
Average Return
+14.42%
Win Rate
57%77 out of 134
Risk vs Reward
Poor
Good
Leonid Timashev's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nuvation Bio IncNUVB | +219.30% | $1.71 | $5.46 | 2025-06-17 - 2026-02-23 | Buy |
Newamsterdam Pharma Co NvNAMS | +164.57% | $7.17 | $18.97 | 2023-10-30 - 2024-10-29 | Buy |
Nuvation Bio IncNUVB | +137.39% | $2.30 | $5.46 | 2025-08-08 - 2026-02-23 | Buy |
Edgewise Therapeutics IncEWTX | +137.30% | $12.68 | $30.09 | 2025-08-08 - 2026-02-23 | Buy |
Edgewise Therapeutics IncEWTX | +131.48% | $7.56 | $17.50 | 2023-06-28 - 2024-06-27 | Buy |
Leonid Timashev Analyst Color
Get additional color on Leonid Timashev's coverage of popular stocks
Leonid Timashev's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 7 | Buy | $101.00 | +47.96% | Maintains | 4 days ago |
Ideaya Biosciences IncIDYA | 5 | Buy | $49.00 | +52.60% | Reiterates | 6 days ago |
Compass Pathways PLCCMPS | 6 | Buy | $22.00 | +180.25% | Maintains | 6 days ago |
Exelixis IncEXEL | 3 | Hold | $46.00 | +4.52% | Maintains | 13 days ago |
Cg Oncology IncCGON | 3 | Buy | $73.00 | +25.19% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 15 | Buy | $219.00 | +25.31% | Maintains | a month ago |
Newamsterdam Pharma Co NvNAMS | 9 | Buy | $47.00 | +29.94% | Maintains | a month ago |
Nuvation Bio IncNUVB | 4 | Buy | $12.00 | +119.78% | Maintains | a month ago |
Cormedix IncCRMD | 3 | Buy | $13.00 | +85.45% | Maintains | a month ago |
Revolution Medicines IncRVMD | 2 | Buy | $140.00 | +35.02% | Maintains | a month ago |
Insmed IncINSM | 8 | Buy | $200.00 | +25.76% | Maintains | a month ago |
Biohaven LtdBHVN | 14 | Buy | $22.00 | +89.98% | Upgrades | a month ago |
Legend Biotech CorpLEGN | 14 | Buy | $66.00 | +234.18% | Maintains | a month ago |
Pyxis Oncology IncPYXS | 7 | Buy | $5.00 | +244.83% | Maintains | 2 months ago |
Design Therapeutics IncDSGN | 10 | Buy | $13.00 | +25.60% | Upgrades | 3 months ago |
Beone Medicines LtdONC | 5 | Buy | $408.00 | +10.08% | Maintains | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Buy | $194.00 | +11.98% | Maintains | 3 months ago |
Jasper Therapeutics IncJSPR | 1 | Hold | $4.00 | +191.97% | Maintains | 3 months ago |
Edgewise Therapeutics IncEWTX | 15 | Buy | $50.00 | +66.17% | Maintains | 4 months ago |
Xencor IncXNCR | 3 | Buy | $19.00 | +64.22% | Maintains | 4 months ago |
Bicycle Therapeutics PLCBCYC | 2 | Hold | $11.00 | +102.21% | Downgrades | 4 months ago |
Alkermes PLCALKS | 5 | Buy | $47.00 | +46.01% | Maintains | 4 months ago |
Verastem IncVSTM | 2 | Buy | $13.00 | +128.07% | Maintains | 7 months ago |
Adc Therapeutics SaADCT | 1 | Buy | $5.00 | +13.38% | Maintains | 8 months ago |
Perspective Therapeutics IncCATX | 1 | Buy | $16.00 | +185.71% | Maintains | 9 months ago |
Brc IncBRCC | 1 | Strong Buy | $3.00 | +380.00% | Maintains | a year ago |
Incyte CorpINCY | 1 | Hold | $70.00 | N/A | Reiterates | a year ago |
Neubase Therapeutics IncNBSE | 1 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.